Medtronic CEO Geoff Martha to Present at J.P. Morgan Healthcare Conference in January 2026

Medtronic CEO Geoff Martha to Speak at J.P. Morgan Healthcare Conference

Medtronic plc, a prominent name in the global healthcare technology sector, is set to make significant waves at the upcoming 44th annual J.P. Morgan healthcare conference scheduled for January 12, 2026. The company, which trades on the New York Stock Exchange under the ticker symbol MDT, has announced that its Chairman and Chief Executive Officer, Geoff Martha, will take the spotlight during this prestigious event.

The presentation is slated to begin at 10:30 AM PST (12:30 PM CST) and will provide attendees with insights into the latest advancements and innovations Medtronic is undertaking to address critical health challenges faced by many today. Following Geoff Martha's comprehensive presentation, Thierry Piéton, the Executive Vice President and Chief Financial Officer of Medtronic, will join him for a Q&A session. This interactive segment promises to enlighten stakeholders on both strategic decisions and potential future directions for the company.

Participants and interested parties will have the opportunity to view a live webcast of the presentation and Q&A session. This will be made accessible through a dedicated section on Medtronic’s investor relations webpage on the date of the conference. For those unable to attend in real-time, an archive of the event will be available shortly after its conclusion, enhancing transparency and engagement with a broader audience.

About Medtronic

Headquartered in Galway, Ireland, Medtronic is renowned for its commitment to tackling the most pressing health issues facing society today. The company's mission — to alleviate pain, restore health, and extend life — is at the core of every initiative they undertake. With a passionate workforce exceeding 95,000 individuals across over 150 countries, Medtronic is pushing the boundaries of what's possible in healthcare.

The company’s portfolio includes innovative solutions for over 70 distinct health conditions, encompassing both hardware and software products, ranging from cardiac devices and insulin pumps to advanced surgical tools and patient monitoring systems. By relentlessly pursuing knowledge and leveraging their diverse team’s expertise, Medtronic consistently delivers cutting-edge technologies that impact lives, aiming to provide transformative healthcare solutions that resonate across the globe.

A Future-Oriented Mindset

As Medtronic gears up for the J.P. Morgan healthcare conference, industry leaders, investors, and healthcare stakeholders anticipate an enlightening discussion that could shape future investment strategies and healthcare initiatives. This event not only reflects Medtronic’s commitment to innovation but also emphasizes the company’s proactive stance in sharing pivotal insights with the broader healthcare community. Mark your calendars for January 12, 2026, as Medtronic continues to stand at the forefront of healthcare advancement.

For more information about Medtronic, please visit www.Medtronic.com and follow them on LinkedIn to stay updated on their latest developments and innovations.